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cDNA	Change	 Protein	Change	 CADD	 Diagnosis	
SLC1A2	 EG1291	(F)	 De	novo	 Pathogenic	a	 chr11:g.35336636	 NM_004171.3:c.244G>C	 p.Gly82Arg	 26.0	 EOEE	
	 T23159	(F)	 De	novo	 Pathogenic	 chr11:g.35336626	 NM_004171.3:c.254T>C	 p.Leu85Pro	 22.3	 EME	
GABRB3	 EG0254	(M)	 De	novo	 Pathogenic	a	 chr15:g.26866564	 NM_000814.4:c.358G>A	 p.Asp120Asn	 36.0	 MAE		 EG0258	(M)	 Segregates	with	GEFS+	family	 Pathogenic	 chr15:g.26828553	 NM_000814.4:c.470C>T	 p.Thr157Met	 24.4	 DS-like		 T22598	(F)	 De	novo	 Pathogenic	b	 chr15:g.	26825603	 NM_000814.4:c.545A>T	 p.Tyr182Phe	 32.0	 EE		 T25111	(F)	 De	novo	 Pathogenic	 chr15:g.26812818	 NM_000814.4:c.745C>A	 p.Gln249Lys	 29.7	 EE		 EG1542	(M)	 De	novo	 Pathogenic	 chr15:g.26812796	 NM_000814.4:c.767T>A	 p.Leu256Gln	 17.6	 EOEE		 T23950	(F)	 Unknown	 Likely	pathogenic	 chr15:g.26806281	 NM_000814.4:c.878T>A	 p.Leu293His	 25.1	 EOEE		 T25708	(M)	 De	novo	 Pathogenic	 chr15:g.26806246	 NM_000814.4:c.913G>A	 p.Ala305Thr	 35.0	 LGS	
CACNA1A	 EG1371	(M)	 De	novo	 Pathogenic	 chr19:g.13566019	 NM_023035.2:c.301G>C	 p.Glu101Gln	 19.1	 EIMFS		 T21924	(F)	 Unknown,	father	unavailable	 VOUS	c	 chr19:g.13476262	 NM_023035.2:c.653C>T	 p.Ser218Leu	 16.6	 EOEE		 T23039	(F)	 De	novo	 Pathogenic	a	 chr19:g.13414398	 NM_023035.2:c.2137G>A	 p.Ala713Thr	 22.1	 EOEE		 T24139	(M)	 Mosaic	mother	 Pathogenic	a	 chr19:g.13414398	 NM_023035.2:c.2137G>A	 p.Ala713Thr	 22.1	 EOEE		 EG1519	(F)	 De	novo	 Pathogenic	 chr19:g.13368235	 NM_023035.2:c.4531G>T	 p.	Ala1511Ser	 20.2	 EOEE	
DNM1	 T24107	(F)	 Mosaic	parent	 Pathogenic	a	 chr9:g.130982480	 NM_004408.2:c.709C>T	 p.Arg237Trp	 19.9	 EE	
GNAO1	 T25023	(M)	 De	novo	 Pathogenic	a	 chr16:g.56385408	 NM_020988.2:c.836T>A	 p.Ile279Asn	 28.6	 EOEE	
IQSEC2	 T17563	(F)	 De	novo	 Pathogenic	 chrX:g.53279555	 NM_001111125.1:c.2203C>T	 p.Gln735*	 39.0	 SGE	



























EEG	 Neuroimaging	 Other	features	 Medicationsa	





EG1291	 6y	F	 EOEE	 Never	normal	 5d	 Epileptic	spasms	 Profound	ID	 Myoclonic	Myoclonic	SE	Tonic	Tonic-clonic	Focal	
Ongoing	 Multifocal	(no	hypsarrhythmia)	 6m:	Delayed	myelination	3y:	Progress	in	myelination,	frontal	atrophy,	thin	CC	 Mild-moderate	generalized	hypotonia	Father:	2	seizures	as	an	adult,	no	further	seizures	on	LTG	 LEV,	VPA,	pyridoxine,	VGB,	prednisolone,	ZNS,	KD	



























EEG	 Neuroimaging	 Other	features	 Medications	a	




T22598	 SUDEP	2y	11mth	F	 EE	 Delayed	 6mth	 Facial	grimace	and	horizontal	head	shaking	with	retained	awareness	
Delayed	 Tonic-clonic	Focal	with	retained	awareness	Focal	SE	Atonic	Atypical	absence	Tonic	
Ongoing	at	death	 Multifocal	Slow	background	 Incomplete	myelination	Plagiocephaly	 Autistic	features	 PB,	CBZ,	MAD	






T23950	 7y	M	 EOEE	 Never	normal	 1mth	 Myoclonic			 Profound	ID	 Tonic	Focal	motor	Clonic	 Unknown	(lost	to	follow	up)	 Multifocal	sharp	waves	 Cortical	atrophy	Thin	CC	Increased	T2	in	globus	pallidus	
Congenital	unilateral	ptosis	Constipation	Hypotonia	Drooling	Dysmorphic	features	
VGB,	PB,	TPM	
EG0258	 9y	M	 Dravet	syndrome-like	 Normal	 8mth	 Febrile		Tonic-clonic	 Mild	ID	Delayed	by	2.5y	 Tonic-clonic	Absence	Myoclonic	Atonic	
Ongoing	 Frontal,	temporal	and	central	sharp	waves	Frontal	and	temporal	R		sharp	waves	
Normal	 Severe	ADHD	Fever	sensitive	seizures	 LTG,	LEV,	STP	
EG1542	 3y	M	 EOEE	 Unknown	 1d	 Tonic-clonic	 Delayed	by	3mth	Severe	ID	 Spasms	Focal	motor	Tonic	 Ongoing	 Hypsarrhythmia	Polymorphous	delta	intermixed	with	polyspikes	Diffuse	background	slowing	
Hypomyelination	 Diffuse	hypotonia	Dyskinesia	 PB,	VGB,	hydrocortisone,	VPA,	LEV,	CLB,	KD	EG0254	 12y	M	 MAE	 Normal	 1y	 Febrile		Tonic-clonic	 Mild	ID	Delayed	by	2.5y	 Myoclonic-atonic	Atonic	Myoclonic	Absence	
1.5y	 2.5-3Hz	GSW	Diffuse	slowing	 Normal	 Stereotyped	behaviour	Learning	disability	 VPA,	LTG,	CLB,	ETX,	TPM	(seizure	free	on	LEV	+	VPA	+	TPM)	




















































T23039	 7y	F	 EOEE	 Normal	until	4mth	 1-2h	 Tonic-clonic	 Severe	ID	 Myoclonic		Focal	CSE	Focal	impaired	awareness	 Ongoing	 GSW	PSW	Mild	slowing	bi-mid	central	frontal	area	
4d:	normal	18mth:	bimesial	temporal	lobe	increased	T2	signal	 Hyperreflexia	Ataxia	Very	active		
VPA,	AZD,	CZP,	PB,	CLB,	TPM,	LTG,	LEV,	ETX	
EG1371	 4y	M	 EIMFS	 Delayed	 4w	 Tonic	with	focal	features	 Severe	ID	 Asymmetric	tonic	Focal	motor	Focal	NCSE	 Ongoing	 Migration	of	rhythmic	left	predominant	2-4	Hz	bi-occipital	activity	to	right	5-6	Hz	theta	activity	L>R	posterior	quadrant	slowing		
2mth:	normal	 Alternating	convergent	strabismus	Cerebral	palsy	 LEV,	STP,	CBZ,	VPA,	TPM,	RFM,	VGB,	ZNS	
EG1519	 12y	F	 EOEE	 Delayed	 1d	 CSE		 Moderate	ID	 2	additional	CSE	at	14mth	and	24mth	without	intervening	seizures	Tonic	with	R	hemifacial	clonic	and	L	eye	deviation		
Ongoing	 Bi-frontal,	L	fronto-central	and	temporal	slowing	 Normal	 Mild	diffuse	hypotonia	Ataxic	gait	Intention	tremor	 TPM,	LTG,	CLB,	VPA,	LEV,	KD	
Individuals	identified	in	Epi,	Epilepsy	Phenome/Genome	et	al.	2013	EPGP011141	 19y	F	 EOEE	à	LGS	 Unremarkable	 1h	 Myoclonic	 Severe	ID	Regression	 Tachypnoeic	episode	Tonic-clonic	Focal	impaired	awareness		CSE	Drop	attacks	Myoclonic	(reflex	to	loud	noise)	Tonic	
Ongoing	 GSW	PSW	Generalised	slowing		
CT	newborn	period:	normal	5w:	normal	SPECT	7y:	areas	of	mildly	decreased	radiopharmaceutical	uptake	in	L	frontal,	parietal	and	temporal	lobes	
Bilateral	alternating	esotropia	Unsustained	nystagmus	on	lateral	gaze	bilaterally	Ataxic	gait	Autism	Generalised	hypotonia	15y:	contractures	
VPA,	VGB,	CLB,	FBM,	CBZ,	GBP,	KD,	LTG,	AZD,	TPM,	VNS,	DZP,	PHT,	PB,	ZNS,	levocarnitine	
ACTH,	adrenocorticotropic	hormone;	ADHD,	attention	deficit	hyperactivity	disorder;	AZD,	acetazolamide;	CBZ,	carbamazepine;	CC,	corpus	callosum;	CLB,	clobazam;	CLZ,	clorazepate;	C-PAP,	continuous	positive	airway	pressure;	CSF,	cerebral	spinal	fluid;	CT,	computed	tomography;	CSE,	convulsive	status	epilepticus;	CZP,	clonazepam;	d,	days;	DZP,	diazepam;	EE,	epileptic	encephalopathy;	EIEE,	early	infantile	epileptic	encephalopathy;	EIMFS,	epilepsy	of	infancy	with	migrating	focal	seizures;	EME,	early	myoclonic	encephalopathy;	EOEE,	early	onset	epileptic	encephalopathy;	ETX,	ethosuxamide;	F,	female;	FBM,	felbamate;	FIAS,	focal	impaired	awareness	seizure;	FS,	febrile	seizures;	GBP,	gabapentin;	GORD,	gastro-oesophageal	reflux	disease;	GPFA,	generalised	paroxysmal	fast	activity;	GSW,	generalised	spike	wave;	h,	hours;	ID,	intellectual	disability;	IS,	infantile	spasms;	KD,	ketogenic	diet;	kg,	kilograms;	L,	left;	LCM,	lacosamide;	LEV,	levetiracetam;	LTG,	lamotrigine;	LGS,	Lennox-Gastaut	Syndrome;	M,	male;	MAD,	modified	Atkins	diet;	MDZ,	midazolam;	mth,	months;	NCSE,	non-convulsive	status	epilepticus;	NG,	nasogastric;	NICU,	neonatal	intensive	care	unit;	NZP,	nitrazepam;	OCBZ,	oxcarbazepine;	PB,	phenobarbitone;	PFA,	paroxysmal	fast	activity;	PHT,	phenytoin;	PRM,	primidone;	PSW,	polyspike	wave;	PEG,	percutaneous	endoscopic	gastrostomy;	R,	right;	RFM,	rufinamide;	sec,	seconds;	SE,	status	epilepticus;	SGE,	symptomatic	generalised	epilepsy;	SPECT,	single-photon	emission	computed	tomography;	STP,	stiripentol;	SSW,	slow	spike	wave;	TPM,	topiramate;	VGB,	vigabatrin;	VNS,	vagus	nerve	stimulation;	VPA,	valproate;	w,	weeks;	y,	years;	ZNS,	zonisamide	a	medications	current	at	last	follow-up	underlined	 	
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